NEW YORK, Sept. 26, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Polymerase Chain Reaction (PCR) Technologies and Global Markets
http://www.reportlinker.com/p0619271/Polymerase-Chain-Reaction-PCR-Technologies-and-Global-Markets.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Genomics
REPORT HIGHLIGHTS
* The global PCR products market is expected to grow from nearly $5 billion in 2010 to nearly $8 billion by 2015, at an estimated compound annual growth rate (CAGR) of 9.9% from 2010 to 2015.
* The reagents and consumables segment accounted for the largest share at nearly $2.7 billion in 2010 and is expected to grow to nearly $4.4 billion at a compound annual growth rate (CAGR) of 10.5% from 2010 to 2015.
* The Instruments segment reached at $1.7 billion in 2010 and is expected to grow to nearly $2.7 billion at a compound annual growth rate (CAGR) of 9.6% from 2010 to 2015.
REPORT SCOPE
INTRODUCTION
STUDY GOALS AND OBJECTIVES
The core objective of the report is to provide an in-depth analysis of the polymerase chain reaction (PCR) market with respect to key market trends, competitive intelligence, and market forecasts. The report also aims at providing key decision-making parameters such as new product launches, market strategies, key application areas to support the market estimates, and forecast data. The report also aims at providing key analysis and strategic recommendations derived from intensive primary and secondary research.
REASONS FOR DOING THIS STUDY
Increasing demand for technologies supporting early and accurate diagnosis of life-threatening diseases, such as cancer, is driving the market for PCR. Additionally, investment in research is increasing with respect to gene therapy, the Human Genome Project (HGP), etc. Despite the economic recession, these investments are further driving the growth of the PCR market. PCR is increasingly being applied in key research that is expected to solve numerous medical mysteries and breakthrough technologies supporting drug discovery. Hence, it is crucial for market participants to understand the growing opportunities and changing market scenarios across the globe. This report therefore aims at providing such crucial information, which will enable companies in this market to make informed decisions.
INTENDED AUDIENCE
Key stakeholders of the report include key decision makers such as CEOs, VPs, AVPs, marketing heads, research heads of the PCR manufacturers, technology providers, software providers, and service providers. The report would also be useful to existing biotech instrumentation players looking to enter high-growth markets. End users, such as healthcare, pharmaceutical companies and drug discovery companies, may also use this report to understand the level of adoption and technology types used in this environment. Universities and consulting firms may derive in-depth market intelligence with respect to the PCR market holistically.
SCOPE AND FORMAT
The key PCR markets covered in the report are the markets for instruments, reagents, consumables and accessories, software, and services, as well as PCR applications and technologies.
The PCR instruments market includes buffers and deoxynucleotide triphosphates [dNTPs] (buffers, contamination control kits, dNTP mixes), controls and cDNAs, primers (real-time PCR primers, human linkage mapping sets, mouse mapping primers), PCR enzymes and kits (contamination control kits, general PCR, fast PCR, multiplex PCR, wax beads for hot start PCR, high-fidelity PCR kits, and other kits), accessories, reaction plates, adhesive films, and thermal cyclers.
The other markets include reagents and consumables, and other accessories (PCR plates and frames, PCR tubes, PCR sealers, PCR plastics). The PCR software market includes primer design and sequencing software, PCR analyzer software, integrated software, and others.
The PCR application market includes research (e.g., genetic testing, gene expression, genetic mapping, tissue typing, hybridization probes, DNA sequencing, the Human Genome Project, forensic science, DNA cloning, bioinformatics, and others), diagnosis (a) infectious disease, for example, HIV, tuberculosis, spread of disease organisms, others, (b) cancer, and (c) prenatal diagnosis and genetic abnormalities, and drug discovery.
The PCR technology market includes inverse PCR, in situ PCR, real-time PCR, reverse transcriptase PCR, nested PCR, long PCR, single cell PCR, and others.
METHODOLOGY AND INFORMATION SOURCES
The market estimates in the report are based on both primary and secondary research. Intensive questionnaire and discussion guides were used to gather data from industry participants, key opinion leaders, and other market specialists across the targeted geographic segments. The market data are further validated through decision support databases and top down market analysis. The secondary research was performed through both paid sources and other domain-based subscription sites and other sources such as company websites, Google searches, freepatentsonline.com, etc.
CHAPTER ONE: INTRODUCTION 1
STUDY GOALS AND OBJECTIVES 1
REASONS FOR DOING THIS STUDY 1
INTENDED AUDIENCE 1
SCOPE AND FORMAT 2
METHODOLOGY AND INFORMATION SOURCES 2
ANALYST CREDENTIALS 3
RELATED BCC RESEARCH REPORTS 3
BCC RESEARCH ONLINE SERVICES 3
DISCLAIMER 4
CHAPTER TWO: SUMMARY 5
SUMMARY 5
SUMMARY TABLE A GLOBAL PCR TECHNOLOGIES MARKET BY
SEGMENT, THROUGH 2015 ($ MILLIONS) 6
SUMMARY FIGURE GLOBAL PCR TECHNOLOGIES MARKET BY
SEGMENT, 2008-2015 ($ MILLIONS) 7
DRIVERS 7
RAPID PROGRESS IN PROTEOMICS AND GENOMICS 7
AVAILABILITY OF FUNDING INCREASES TECHNOLOGY
DEVELOPMENT AND ADOPTION 8
RAPID GROWTH IN MOLECULAR DIAGNOSTIC INDUSTRY 9
PRODUCT INNOVATIONS INCREASE TECHNOLOGY
ADOPTION AND APPLICATION AREAS 10
WIDE RANGE OF APPLICATIONS 11
RESTRAINTS 11
LACK OF AWARENESS 11
REQUIREMENT OF SKILLED LABOR 11
HIGH COST OF REAL-TIME PCR INSTRUMENTS 12
DEVELOPMENT OF ALTERNATIVE TECHNOLOGIES 12
OPPORTUNITIES AND CHALLENGES 12
SUMMARY TABLE B GLOBAL PCR TECHNOLOGIES MARKET BY
GEOGRAPHIC REGION, THROUGH 2015 ($ MILLIONS) 13
CHAPTER THREE: MARKET OVERVIEW 14
EVOLUTION OF PCR TECHNOLOGY AND ITS IMPACT ON THE
HEALTHCARE INDUSTRY 14
FIGURE 1 IMPACT OF PCR TECHNOLOGY ON THE HEALTHCARE
ENVIRONMENT 15
TRADITIONAL PCR VERSUS REAL-TIME PCR 16
TABLE 1 TRADITIONAL PCR VERSUS REAL-TIME PCR 16
KEY APPLICATION AREAS 17
FIGURE 2 KEY APPLICATIONS OF PCR TECHNOLOGY 17
PCR QUANTITATION METHODS 18
THE HUMAN GENOME PROJECT AND PCR 19
HUMAN MICROBIOME PROJECT AND PCR 20
TAQMAN PROBES AND MOLECULAR BEACONS: POTENTIAL
ALTERNATIVES TO DYES USED IN REAL-TIME PCR 21
ALTERNATIVES TO PCR-BASED ANALYTICAL METHODS 22
FIGURE 3 DISADVANTAGES OF PCR VS THE ADVANTAGES OF
ALTERNATIVES 22
LOOP MEDIATED ISOTHERMAL AMPLIFICATION 23
REACTION DISPLACEMENT CHIMERIC 24
NUCLEIC ACID SEQUENCE-BASED AMPLIFICATION 24
TRANSCRIPTION-MEDIATED AMPLIFICATION 24
KEY APPLICATION AREAS 25
FIGURE 4 KEY APPLICATIONS OF PCR 25
PCR AND PUBLIC HEALTH SURVEILLANCE 26
PCR AND PUBLIC HEALTH SURVEILLANCE (CONTINUED) 27
EMERGING ECONOMIES AND TECHNOLOGY ADOPTION 28
FUTURE OF PCR 28
MARKET TRENDS/KEY INSIGHTS 29
KEY RECOMMENDATIONS/MARKET STRATEGIES 29
PATENT ANALYSIS 30
FIGURE 5 PATENT ANALYSIS BY GEOGRAPHIC REGION, 2008–2010
(%) 31
FIGURE 6 PATENT ANALYSIS BY TYPE OF PRODUCT, 2008–2010 (%) 32
CHAPTER FOUR: PCR MARKET SEGMENTS 33
INSTRUMENTS MARKET 33
TABLE 2 GLOBAL PCR INSTRUMENTS MARKET BY PRODUCT
TYPE, THROUGH 2015 ($ MILLIONS) 33
TABLE 3 GLOBAL PCR INSTRUMENTS MARKET BY GEOGRAPHIC
REGION, THROUGH 2015 ($ MILLIONS) 34
DRIVERS AND RESTRAINTS 34
MARKET FLOODED WITH CHOICE OF INSTRUMENTS
WITH A WIDE RANGE OF PRICES 34
GROWING POPULARITY OF REAL-TIME PCR
INSTRUMENTS 35
RAPIDLY CHANGING MARKET DEMAND 36
TRADITIONAL THERMAL CYCLERS/THERMAL CYCLERS 36
TABLE 4 GLOBAL THERMAL CYCLERS MARKET BY GEOGRAPHIC
REGION, THROUGH 2015 ($ MILLIONS) 37
REAL-TIME PCR INSTRUMENTS/REAL-TIME THERMAL
CYCLERS 37
TABLE 5 GLOBAL REAL-TIME PCR INSTRUMENTS MARKET BY
GEOGRAPHIC REGION, THROUGH 2015 ($ MILLIONS) 38
OTHERS 38
TABLE 6 GLOBAL OTHER INSTRUMENTS MARKET BY
GEOGRAPHIC REGION, THROUGH 2015 ($ MILLIONS) 38
REAGENTS AND CONSUMABLES MARKET 39
TABLE 7 GLOBAL REAGENTS AND CONSUMABLES MARKET BY
PRODUCT TYPE, THROUGH 2015 ($ MILLIONS) 39
TABLE 8 GLOBAL REAGENTS AND CONSUMABLES MARKET BY
GEOGRAPHIC REGION, THROUGH 2015 ($ MILLIONS) 40
DRIVERS 40
Increased Use of PCR Technology 40
Master Mixes and Ready-to-Use Kits Boost the Market 41
RESTRAINTS 41
REAGENTS 42
TABLE 9 GLOBAL REAGENTS MARKET BY PRODUCT TYPE,
THROUGH 2015 ($ MILLIONS) 42
TABLE 10 GLOBAL REAGENTS MARKET BY GEOGRAPHIC REGION,
THROUGH 2015 ($ MILLIONS) 43
Individual Reagents 43
TABLE 11 GLOBAL INDIVIDUAL REAGENTS BY PRODUCT TYPE,
THROUGH 2015 ($ MILLIONS) 43
TABLE 12 GLOBAL INDIVIDUAL REAGENTS BY GEOGRAPHIC
REGION, THROUGH 2015 ($ MILLIONS) 44
Enzymes 44
TABLE 13 GLOBAL ENZYMES MARKET BY GEOGRAPHIC REGION,
THROUGH 2015 ($ MILLIONS) 45
Deoxynucleotide Triphosphates 45
TABLE 14 GLOBAL DNTP MARKET BY GEOGRAPHIC REGION,
THROUGH 2015 ($ MILLIONS) 46
Buffers/Reaction Buffers and Additives 46
TABLE 15 GLOBAL BUFFERS AND ADDITIVES MARKET BY
GEOGRAPHIC REGION, THROUGH 2015 ($ MILLIONS) 47
Primers and Probes 47
TABLE 16 GLOBAL PRIMERS AND PROBES MARKET BY
GEOGRAPHIC REGION, THROUGH 2015 ($ MILLIONS) 48
Controls/Templates 48
TABLE 17 GLOBAL TEMPLATES MARKET BY GEOGRAPHIC
REGION, THROUGH 2015 ($ MILLIONS) 49
Master Mixes/Reagents Kits 49
TABLE 18 GLOBAL MASTER MIXES MARKET BY GEOGRAPHIC
REGION, THROUGH 2015 ($ MILLIONS) 50
Other Reagents 50
TABLE 19 GLOBAL OTHER REAGENTS MARKET BY GEOGRAPHIC
REGION, THROUGH 2015 ($ MILLIONS) 50
CONSUMABLES 51
TABLE 20 GLOBAL CONSUMABLES MARKET BY GEOGRAPHIC
REGION, THROUGH 2015 ($ MILLIONS) 51
PCR SOFTWARE 51
TABLE 21 GLOBAL PCR SOFTWARE MARKET BY PRODUCT TYPE,
THROUGH 2015 ($ MILLIONS) 52
TABLE 22 GLOBAL PCR SOFTWARE MARKET BY GEOGRAPHIC
REGION, THROUGH 2015 ($ MILLIONS) 52
PRIMER DESIGN AND SEQUENCING SOFTWARE 53
TABLE 23 GLOBAL PRIMER DESIGN AND SEQUENCING
SOFTWARE MARKET BY GEOGRAPHIC REGION, THROUGH 2015
($ MILLIONS) 53
PCR ANALYZER SOFTWARE 53
TABLE 24 GLOBAL PCR ANALYZER SOFTWARE MARKET BY
GEOGRAPHIC REGION, THROUGH 2015 ($ MILLIONS) 54
OTHER SOFTWARE MARKET 54
TABLE 25 GLOBAL OTHER SOFTWARE MARKET BY GEOGRAPHIC
REGION, THROUGH 2015 ($ MILLIONS) 54
SERVICES 55
TABLE 26 GLOBAL PCR SERVICE MARKET BY GEOGRAPHIC
REGION, THROUGH 2015 ($ MILLIONS) 55
CHAPTER FIVE: PCR APPLICATION MARKET 56
TABLE 27 GLOBAL APPLICATION MARKET BY SEGMENT,
THROUGH 2015 ($ MILLIONS) 56
TABLE 28 GLOBAL APPLICATION MARKET BY GEOGRAPHIC
REGION, THROUGH 2015 ($ MILLIONS) 57
DRIVERS 57
PRESSING NEED FOR MANAGEMENT OF INFECTIOUS
AND FATAL DISEASES 57
IMPROVEMENTS IN PCR PRODUCTS AND AVAILABILITY
HAVE FACILITATED USE 57
CAPABILITY TO ANALYZE OLD/ANCIENT SAMPLES 58
FOCUS ON PREVENTIVE HEALTHCARE 58
DEMAND FOR GENETIC, MOLECULAR DIAGNOSTIC
TESTING 59
NEWER TECHNOLOGIES AND AN INCREASE IN END
USERS 59
RESTRAINTS AND CHALLENGES 59
RESEARCH APPLICATIONS 60
TABLE 29 GLOBAL RESEARCH MARKET BY APPLICATION TYPE,
THROUGH 2015 ($ MILLIONS) 60
TABLE 30 GLOBAL RESEARCH APPLICATION MARKET BY
GEOGRAPHIC REGION, THROUGH 2015 ($ MILLIONS) 61
DNA SEQUENCING 61
TABLE 31 GLOBAL DNA SEQUENCING MARKET BY GEOGRAPHIC
REGION, THROUGH 2015 ($ MILLIONS) 62
FORENSIC SCIENCE 62
Forensic Science (Continued) 63
TABLE 32 GLOBAL FORENSIC SCIENCE MARKET BY GEOGRAPHIC
REGION, 2008–2015 ($ MILLIONS) 64
GENOTYPING 64
TABLE 33 GLOBAL GENOTYPING MARKET BY GEOGRAPHIC
REGION, THROUGH 2015 ($ MILLIONS) 65
BIOINFORMATICS 65
TABLE 34 GLOBAL BIOINFORMATICS MARKET BY GEOGRAPHIC
REGION, THROUGH 2015 ($ MILLIONS) 66
GENE EXPRESSION AND GENETIC MAPPING 66
TABLE 35 GLOBAL GENE EXPRESSION AND GENETIC MAPPING
MARKET BY GEOGRAPHIC REGION, THROUGH 2015 ($
MILLIONS) 67
DNA CLONING 67
TABLE 36 GLOBAL DNA CLONING MARKET BY GEOGRAPHIC
REGION, THROUGH 2015 ($ MILLIONS) 68
OTHERS 68
TABLE 37 GLOBAL OTHER RESEARCH APPLICATIONS MARKET BY
GEOGRAPHIC REGION, THROUGH 2015 ($ MILLIONS) 68
CLINICAL APPLICATIONS 69
TABLE 38 GLOBAL PCR MARKET BY TYPE OF CLINICAL
APPLICATION, THROUGH 2015 ($ MILLIONS) 69
TABLE 39 GLOBAL CLINICAL APPLICATIONS MARKET BY
GEOGRAPHIC REGION, THROUGH 2015 ($ MILLIONS) 70
PRENATAL DIAGNOSIS 70
TABLE 40 GLOBAL MARKET FOR PCR IN PRENATAL DIAGNOSTICS
BY GEOGRAPHIC REGION, THROUGH 2015 ($ MILLIONS) 70
TISSUE TYPING/TRANSPLANT 71
TABLE 41 GLOBAL PCR TISSUE TYPING/TRANSPLANT
INSTRUMENTS MARKET BY GEOGRAPHIC REGION, THROUGH
2015 ($ MILLIONS) 71
CANCER THERAPY AND DETERMINATION 71
TABLE 42 GLOBAL MARKET FOR PCR TESTING IN CANCER
THERAPY BY GEOGRAPHIC REGION, THROUGH 2015 ($
MILLIONS) 72
INFECTIOUS DISEASE DIAGNOSIS 72
TABLE 43 GLOBAL MARKET FOR PCR IN THE TESTING OF
INFECTIOUS DISEASES BY APPLICATION TYPE, THROUGH
2015 ($ MILLIONS) 73
TABLE 44 GLOBAL MARKET FOR PCR IN THE TESTING OF
INFECTIOUS DISEASES BY GEOGRAPHIC REGION, THROUGH
2015 ($ MILLIONS) 73
Hepatitis B and Hepatitis C Testing 74
TABLE 45 GLOBAL MARKET FOR PCR IN HEPATITIS B AND C
TESTING BY GEOGRAPHIC REGION, THROUGH 2015 ($
MILLIONS) 75
Tuberculosis Diagnosis 75
TABLE 46 GLOBAL MARKET FOR PCR IN TUBERCULOSIS TESTING
BY GEOGRAPHIC REGION, THROUGH 2015 ($ MILLIONS) 76
HIV/AIDS Diagnosis 76
TABLE 47 GLOBAL HIV TESTING MARKET BY GEOGRAPHIC
REGION, THROUGH 2015 ($ MILLIONS) 77
Other Infectious Diseases 77
TABLE 48 GLOBAL MARKET FOR PCR TESTING OF OTHER
INFECTIOUS DISEASES BY GEOGRAPHIC REGION, THROUGH
2015 ($ MILLIONS) 77
GENETIC TESTING 78
TABLE 49 GLOBAL GENETIC TESTING MARKET BY GEOGRAPHIC
REGION, THROUGH 2015 ($ MILLIONS) 78
BLOOD SCREENING 79
TABLE 50 GLOBAL MARKET FOR PCR BLOOD SCREENING TESTS
BY GEOGRAPHIC REGION, THROUGH 2015 ($ MILLIONS) 79
OTHER PCR APPLICATIONS 79
TABLE 51 GLOBAL "OTHER" PCR APPLICATIONS MARKET BY
GEOGRAPHIC REGION, THROUGH 2015 ($ MILLIONS) 80
CHAPTER SIX: PCR TECHNOLOGY MARKET 81
TECHNOLOGY TYPES 81
TABLE 52 GLOBAL PCR TECHNOLOGY MARKET BY TYPE,
THROUGH 2015 ($ MILLIONS) 81
TABLE 53 GLOBAL PCR TECHNOLOGY MARKET BY GEOGRAPHIC
REGION, THROUGH 2015 ($ MILLIONS) 82
MARKET DRIVERS 82
WIDE RANGE OF APPLICATIONS DRIVING TECHNOLOGY
ACCEPTANCE 82
TECHNOLOGICAL VARIANTS OPEN NEW AVENUES FOR
PCR TECHNOLOGY 83
PCR TECHNOLOGY PATENT EXPIRY HAS BOOSTED
MARKET GROWTH 83
CHALLENGES 84
STANDARD/BASIC PCR 84
TABLE 54 GLOBAL STANDARD PCR MARKET BY GEOGRAPHIC
REGION, THROUGH 2015 ($ MILLIONS) 84
REAL-TIME PCR/QPCR 85
TABLE 55 GLOBAL REAL-TIME PCR/QPCR MARKET BY
GEOGRAPHIC REGION, THROUGH 2015 ($ MILLIONS) 86
REVERSE TRANSCRIPTASE PCR 86
TABLE 56 GLOBAL REVERSE TRANSCRIPTION PCR MARKET BY
GEOGRAPHIC REGION, THROUGH 2015 ($ MILLIONS) 87
ASSEMBLY PCR 87
TABLE 57 GLOBAL ASSEMBLY PCR MARKET BY GEOGRAPHIC
REGION, THROUGH 2015 ($ MILLIONS) 88
INVERSE PCR 88
TABLE 58 GLOBAL INVERSE MARKET BY GEOGRAPHIC REGION,
THROUGH 2015 ($ MILLIONS) 89
NESTED PCR 89
TABLE 59 GLOBAL NESTED PCR MARKET BY GEOGRAPHIC
REGION, THROUGH 2015 ($ MILLIONS) 90
MULTIPLEX PCR 90
TABLE 60 GLOBAL MULTIPLEX PCR MARKET BY GEOGRAPHIC
REGION, THROUGH 2015 ($ MILLIONS) 90
HOT START AND TOUCHDOWN PCR 91
TABLE 61 GLOBAL HOT START AND TOUCHDOWN PCR MARKET
BY GEOGRAPHIC REGION, THROUGH 2015 ($ MILLIONS) 91
OTHERS 92
TABLE 62 GLOBAL OTHER TECHNOLOGY TYPES BY GEOGRAPHIC
REGION, THROUGH 2015 ($ MILLIONS) 92
CHAPTER SEVEN: COMPETITIVE LANDSCAPE 93
FIGURE 7 PCR MARKET STRATEGIES BY TYPE, MARCH 2008-2010
(%) 93
COMPETITIVE LANDSCAPE (CONTINUED) 94
FIGURE 8 KEY PLAYERS IN STRATEGIC DEVELOPMENT (%) 95
TABLE 63 MERGERS AND ACQUISITIONS 96
TABLE 64 NEW PRODUCT LAUNCHES, JUNE 2008-MAY 2011 96
TABLE 64 (CONTINUED) 97
TABLE 65 AGREEMENTS AND COLLABORATIONS, JUNE 2008 TO
JUNE 2011 97
TABLE 65 (CONTINUED) 98
CHAPTER EIGHT: GEOGRAPHIC ANALYSIS OF THE PCR
APPLICATIONS MARKET 99
FIGURE 9 TOTAL PCR MARKET BY GEOGRAPHIC REGION, 2010 VS
2015 (%) 99
FIGURE 9 (CONTINUED) 100
NORTH AMERICA 101
TABLE 66 NORTH AMERICAN PCR MARKET BY SEGMENT, 2008–
2015 ($ MILLIONS) 101
EUROPE 101
TABLE 67 EUROPEAN PCR MARKET BY SEGMENT, 2008–2015 ($
MILLIONS) 102
ASIA 102
TABLE 68 ASIAN PCR MARKET BY SEGMENT, THROUGH 2015 ($
MILLIONS) 103
ROW 103
TABLE 69 ROW PCR MARKET BY SEGMENT, THROUGH 2015 ($
MILLIONS) 104
CHAPTER NINE: COMPANY PROFILES 105
ABBOTT LABORATORIES 105
TABLE 70 RECENT DEVELOPMENTS 105
TABLE 70 (CONTINUED) 106
AFFYMETRIX, INC 106
TABLE 71 RECENT DEVELOPMENTS 107
AGILENT TECHNOLOGIES 107
TABLE 72 RECENT DEVELOPMENTS 108
BECKMAN COULTER, INC 109
TABLE 73 RECENT DEVELOPMENTS 110
BECTON, DICKINSON AND CO 110
TABLE 74 RECENT DEVELOPMENTS 111
BIOLINE 112
BIONEER, INC 112
TABLE 75 RECENT DEVELOPMENTS 113
BIO-RAD 114
TABLE 76 RECENT DEVELOPMENTS 114
COMPLETE GENOMICS 115
TABLE 77 RECENT DEVELOPMENTS 115
TABLE 77 (CONTINUED) 116
THE ELITECH GROUP (NANOGEN/EPOCH BIOSCIENCES) 116
ENZO LIFE SCIENCES (ENZO BIOCHEM SUBSIDIARY) 117
EXIQON 117
TABLE 78 RECENT DEVELOPMENTS 118
GE HEALTHCARE 119
TABLE 79 RECENT DEVELOPMENTS 119
GEN-PROBE, INC 120
TABLE 80 RECENT DEVELOPMENTS 120
HY LABORATORIES (HY LABS) 121
IDAHO TECHNOLOGY, INC 121
TABLE 81 RECENT DEVELOPMENTS 122
ILLUMINA 123
TABLE 82 RECENT DEVELOPMENTS 124
KAPA BIOSYSTEMS 124
LIFE TECHNOLOGIES CORP/APPLIED BIOSYSTEMS AND
INVITROGEN 125
TABLE 83 RECENT DEVELOPMENTS 126
TABLE 83 (CONTINUED) 127
LUCIGEN 128
MAXIM BIOTECH 128
NEW ENGLAND BIOLABS (NEB) 129
TABLE 84 RECENT DEVELOPMENTS 130
OCIMUM BIOSOLUTIONS, LTD 130
PROMEGA CORP 131
TABLE 85 RECENT DEVELOPMENTS 132
QIAGEN NV 133
TABLE 86 RECENT DEVELOPMENTS 133
TABLE 86 (CONTINUED) 134
TABLE 86 (CONTINUED) 135
ROCHE 136
TABLE 87 RECENT DEVELOPMENTS 137
TABLE 87 (CONTINUED) 138
TABLE 87 (CONTINUED) 139
SIGMA-ALDRICH CORP 139
TABLE 88 RECENT DEVELOPMENTS 140
TABLE 88 (CONTINUED) 141
TAKARA BIO 142
TABLE 89 RECENT DEVELOPMENTS 143
THERMO FISHER SCIENTIFIC 143
TABLE 90 RECENT DEVELOPMENTS 144
QUANTA BIOSCIENCES 145
APPENDIX: LIST OF PATENTS 146
TABLE 91 US PATENTS AND PATENT APPLICATIONS (2008 TO
2011) 146
TABLE 93 JAPANESE PATENTS (2008 TO 2011) 155
To order this report:
Genomics Industry: Polymerase Chain Reaction (PCR) Technologies and Global Markets
Genomics Business News
Check our Industry Analysis and Insights
__________________________
Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626
SOURCE Reportlinker
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article